CLMT, US1314281049

Calumet schedules results: seven analysts rate Calumet stock Hold

Published on 10/06/2026 at 14:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Calumet stock was last at EUR 47.76 on Tradegate on September 23, 2026. Third-quarter results are set for November 6, 2026 at 9:00 a.m. ET.

CLMT, US1314281049, Illustration mit AI erstellt.
CLMT, US1314281049, Illustration mit AI erstellt.

Calumet, Inc. (ISIN US1314281049) was last at EUR 47.76 on Tradegate on September 23, 2026. According to Placera.se on October 6, 2026, Calumet plans to report third-quarter 2026 results on November 6, 2026, with a conference call at 9:00 a.m. ET. MarketBeat reports that seven brokerages rate the stock Hold.

November results set the next test

The November report will follow Calumet's second-quarter performance, which combined sharp sales growth with a continuing net loss. The timing gives investors a defined date for testing whether improved operating performance can offset financing and non-cash charges.

MarketBeat puts the average 12-month target at USD 51.75, while its analyst tally comprises four Holds, two Buys and one Sell. The target is a separate US-dollar reference and is not combined with the euro Tradegate quotation.

Revenue grows while losses persist

For the second quarter of 2026, Calumet reported revenue of USD 1.45 billion, up 40.8 percent from the second quarter of 2025, according to StockTitan. The company still posted a net loss of USD 95.9 million, or USD 1.09 per share, compared with a USD 147.9 million loss in the year-earlier quarter.

Adjusted EBITDA increased to USD 159.3 million from USD 55.1 million in the second quarter of 2025. That contrast matters: revenue expanded by 40.8 percent year over year, while statutory profitability remained negative and the quarterly loss narrowed by USD 52.0 million.

Operating cash flow was USD 92.3 million in the second quarter of 2026, compared with negative USD 1.8 million in the second quarter of 2025. Total assets stood at USD 2.8 billion on June 30, 2026, according to the Q2 filing summary.

Stock range and market value

The Tradegate substitute price was EUR 47.76 on September 23, 2026. Calumet's market capitalization was USD 4.9 billion as of October 6, 2026, while the 52-week range was USD 17.42 to USD 59.87. Those figures use different quotation currencies and are presented separately from the euro price.

Calumet stock snapshot

  • Company: Calumet, Inc.
  • ISIN: US1314281049
  • Ticker: CLMT
  • Primary exchange: NASDAQ
  • Substitute price Tradegate (as of September 23, 2026): EUR 47.76
  • Market capitalization: USD 4.9 billion (as of October 6, 2026)
  • 52-week range: USD 17.42-59.87 (as of October 6, 2026)
  • Sector / Industry: Basic Materials / Specialty Chemicals
  • Next earnings date: November 6, 2026

More news and analysis on Calumet stock

Disclaimer...

en | US1314281049 | CLMT | boerse | 70242361 | bgmi